Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Fibrosis, the accumulation of scar tissue in organs, disrupts normal organ function and leads to progressive impairment. Currently, there is no cure, and existing treatments focus primarily on symptom management…
Continue Reading
Breaking the Fibrosis Barrier: How Fibrocor Therapeutics Is Revolutionizing Kidney Disease Treatment
Ovarian cancer is a serious gynecological cancer with no reliable screening test, resulting in limited treatment options and a low number of survivors. Each year about 3,100 Canadians receive a…
Continue Reading
British Columbia Researchers Develop a System to Reduce Ovarian Cancer by 80%
CAR-NKT cell therapy (NKT) is capable of precision targeting when equipped with CAR. The UCLA study’s co-senior author, Dr. Lili Yang stated that personalized immunotherapies in use today may cost…
Continue Reading
A New Treatment to Fight Ovarian Cancer has been Developed by UCLA Scientists
Ever since Celine Dion, the popular superstar, announced the cancellation of her 2023 tour due to a diagnosis of Stiff Person Syndrome, or SPS, the disease has been in the…
Continue Reading
Celine Dion’s Stiff Person Syndrome Treatment and Progress
It took two new cases of the deadly Nipah virus to remind people in West Bengal, India of the 1998 outbreak that killed over one hundred people. Nevertheless, according to…
Continue Reading
Who is at Risk of Getting the Deadly Nipah Virus?
Scientists find polymer-coated nanoparticles together with therapeutic drugs offer promise for cancer treatment, including treatment for ovarian cancer. According to Science Daily, these nanoparticles may be targeted to tumors where…
Continue Reading
Nanoparticles Targeting Tumors Eliminates Most Chemotherapy Side Effects
Several highly esteemed Institutes such as the Mayo Clinic and CONICET have identified critical elements contributing to the aggressiveness of Pancreatic cancer. The survival rate at the five-year mark is…
Continue Reading
An International Team of Researchers Identify a New Key Factor Influencing Pancreatic Cancer
Iowa University researchers at its Children’s Hospital led the effort that found a new target. According to the Iowa Carver College of Medicine, to date, efforts by researchers focused on…
Continue Reading
FDA Approve Drug That Targets Root Cause of Life-Threatening Kidney Disease Affecting Children and Young Adults
A rare and life-threatening kidney disease affecting young adults and children finally has an effective and approved therapy due to the pioneering and leadership of researchers at the Iowa University’s…
Continue Reading
The FDA Approves a Drug that Brought a 67% Reduction in a Life-Threatening Kidney Disease Affecting Young Adults and Children
A team of doctors at NYU Langone transplanted a pig kidney into a brain-dead patient and reversed its rejection twice during the 61-day study. Currently, estimates of the number of…
Continue Reading
NYU Langone Doctors Transplanted a Pig Kidney into a Brain Dead Patient Reversing Rejection Twice
There may be several reasons that HCC cancer of the liver cannot be removed. It may be due to the size of the tumor, or location proximity to major blood…
Continue Reading
New Study Finds Keytruda Combo Falls Short of Expectations in Unresectable-Non-Metastatic Hepatocellular Carcinoma
Breaking a system into small independent and interchangeable modules that can perform certain functions is called modularity. For many years the KRAS oncogene proved to be a classic example of…
Continue Reading
The Ever growing Field of Molecular Glues
Light chain amyloidosis (AL) is a progressive and rare disease whereby abnormal plasma cells found in the blood and urine over-produce light chain proteins. These proteins misfold into amyloid fibrils…
Continue Reading
The FDA Grants Traditional Approval for Daratumumab Regime in Amyloidosis
The findings were recently published in Nature Immunology and reported by Precision Medicine suggesting that a factor called Interferon Regulatory Factor 4 (IRF4) takes responsibility as a driver of transplant…
Continue Reading
Houston Methodist Researchers Identify T Cells That Attack Transplanted Organs
A gene-editing protein, small enough to fit into adeno-associated viruses (AAVs) that infect humans has been identified. As reported by Precision Medicine, these compact AAVs can be modified so that…
Continue Reading
CRISPR-Cas Technologies and the Potential for Revolutionizing Genetic Medicine
The developer of the Promega OncoMate MSI Dx Analysis System recently announced the FDA’s approval of the system identifying patients who may benefit from the combination of Lenvatinib (Lenvima) and…
Continue Reading
FDA Approves Evaluating the OcoMate Dx Analysis System
Please go HERE to read Part 1 of this article The company, GEMMABIO, will pursue a number of rare, large indications. A new spinout, RareTx, will be dedicated to Orphan…
Continue Reading
Jim Wilson’s Pioneering Journey: Transforming Rare Disease Treatment Through Innovative Gene Therapy Part 2
Professor Zdeněk Sofer of the University of Prague and his team developed and validated a "Lab-on-a-Scalpel" concept which is a surgical tool incorporating an integrated diagnostic sensor. Their findings were…
Continue Reading
Researchers at University of Prague Unveil Lab-on-a-Scalpel
As noted in a recent article published in Inside Precision Medicine, in 1992 gene therapy was often discussed but seldom practiced. When Jim Wilson MD, PhD attended Penn State, gene…
Continue Reading
Jim Wilson’s Pioneering Journey: Transforming Rare Disease Treatment Through Innovative Gene Therapy Part 1
Xspray Pharma, the developer of the drug dasatinib, was recently issued a Complete Response Letter (CRL) by the FDA while waiting for corrective actions, according to Cancer Network. Based on…
Continue Reading
The FDA has Issued a Complete Response Letter to Xspray Pharma Delaying Approvals Affecting ALL and CML
According to a press release from Syndax Pharmaceuticals, the developer of Revumenib, the drug met its primary endpoint resulting in complete remission (CR) or CR with partial recovery. Relapsed or…
Continue Reading
Syndax Pharmaceutical’s Revumenib Meets its Primary Endpoint to Treat Relaxed/Refractory Acute AML
A recently published study in The Lancet reports that over 54,600 children living in Gaza are severely malnourished. In addition, as of August 2025, there are few therapeutic options available…
Continue Reading
New Lancet Study Highlights Severe Malnutrition in Gaza
Over 9,300 individuals living in the United States are currently waiting for a liver transplant. There is a serious need for liver donors. This message was recently sent out by…
Continue Reading
Urgent Message from the American Liver Foundation
Immuneering’s midstage pancreatic deep cyclic MEK protein inhibitor, (DCI), almost doubled the standard overall survival. It is a deep cycle inhibitor that targets key pathways in a pulsed manner. Results…
Continue Reading
Overall Survival Nearly Doubles in Immuneering’s Midstage Pancreatic Cancer Trial
A recent study by UCLA researchers of in-home murders of children twelve and under revealed that according to the National Violent Death Reporting System and other agencies, nearly one quarter…
Continue Reading
In-Home Homicides of Young Children In their Own Home More than Doubled from 2001 to 2020